Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Oct;39(10):2367–2370. doi: 10.1128/aac.39.10.2367

Emergence of in vitro resistance to fluoroquinolones in Neisseria gonorrhoeae isolated in Japan.

M Tanaka 1, T Matsumoto 1, I Kobayashi 1, U Uchino 1, J Kumazawa 1
PMCID: PMC162948  PMID: 8619601

Abstract

To investigate emerging fluoroquinolone resistance in Neisseria gonorrhoeae isolated in Japan, we compared the in vitro antimicrobial susceptibilities of 79 gonococcal isolates from 1992 through 1993 to 14 fluoroquinolones and 14 other antibiotics with those of 27 isolates from between 1981 and 1984. The MICs at which 90% of the isolates were inhibited by nine fluroquinolones, including norfloxacin, enoxacin, ofloxacin, ciprofloxacin, tosufloxacin, lomefloxacin, fleroxacin, levofloxacin, and sparfloxacin, for isolates from 1992 to 1993 were 8- or 16-fold higher than those for isolates from 1981 to 1984. Furthermore, the MICs at which 90% of the isolates were inhibited by five fluroquinolones, including OPC-17116, T-3761, DU-6859a, AM-1155, and Q-35, that have recently been synthesized but have not yet been introduced for clinical use in Japan for isolates from 1992 to 1993 were also 2- to 16-fold higher than those for isolates from 1981 to 1984. The gonococcal isolates from 1992 to 1993 showed no significant decreases in susceptibility to beta-lactams, tetracyclines, macrolides, and spectinomycin, compared with those for isolates from 1981 to 1984. Our data indicate that the incidence of gonococcal strains with decreased susceptibilities to fluoroquinolones is increasing in Japan.

Full Text

The Full Text of this article is available as a PDF (177.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Black J. R., Long J. M., Zwickl B. E., Ray B. S., Verdon M. S., Wetherby S., Hook E. W., 3rd, Handsfield H. H. Multicenter randomized study of single-dose ofloxacin versus amoxicillin-probenecid for treatment of uncomplicated gonococcal infection. Antimicrob Agents Chemother. 1989 Feb;33(2):167–170. doi: 10.1128/aac.33.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bogaerts J., Tello W. M., Akingeneye J., Mukantabana V., Van Dyck E., Piot P. Effectiveness of norfloxacin and ofloxacin for treatment of gonorrhoea and decrease of in vitro susceptibility to quinolones over time in Rwanda. Genitourin Med. 1993 Jun;69(3):196–200. doi: 10.1136/sti.69.3.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brett M. S., Davies H. G., Blockley J. R., Heffernan H. M. Antibiotic susceptibilities, serotypes and auxotypes of Neisseria gonorrhoeae isolated in New Zealand. Genitourin Med. 1992 Oct;68(5):321–324. doi: 10.1136/sti.68.5.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chu M. L., Ho L. J., Lin H. C., Wu Y. C. Epidemiology of penicillin-resistant Neisseria gonorrhoeae isolated in Taiwan, 1960-1990. Clin Infect Dis. 1992 Feb;14(2):450–457. doi: 10.1093/clinids/14.2.450. [DOI] [PubMed] [Google Scholar]
  5. Clendennen T. E., 3rd, Hames C. S., Kees E. S., Price F. C., Rueppel W. J., Andrada A. B., Espinosa G. E., Kabrerra G., Wignall F. S. In vitro antibiotic susceptibilities of Neisseria gonorrhoeae isolates in the Philippines. Antimicrob Agents Chemother. 1992 Feb;36(2):277–282. doi: 10.1128/aac.36.2.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Clendennen T. E., Echeverria P., Saengeur S., Kees E. S., Boslego J. W., Wignall F. S. Antibiotic susceptibility survey of Neisseria gonorrhoeae in Thailand. Antimicrob Agents Chemother. 1992 Aug;36(8):1682–1687. doi: 10.1128/aac.36.8.1682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gransden W. R., Warren C. A., Phillips I., Hodges M., Barlow D. Decreased susceptibility of Neisseria gonorrhoeae to ciprofloxacin. Lancet. 1990 Jan 6;335(8680):51–51. doi: 10.1016/0140-6736(90)90177-7. [DOI] [PubMed] [Google Scholar]
  8. Gransden W. R., Warren C., Phillips I. 4-Quinolone-resistant Neisseria gonorrhoeae in the United Kingdom. J Med Microbiol. 1991 Jan;34(1):23–27. doi: 10.1099/00222615-34-1-23. [DOI] [PubMed] [Google Scholar]
  9. Ison C. A., Branley N. S., Kirtland K., Easmon C. S. Surveillance of antibiotic resistance in clinical isolates of Neisseria gonorrhoeae. BMJ. 1991 Nov 23;303(6813):1307–1307. doi: 10.1136/bmj.303.6813.1307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ison C. A., Pepin J., Roope N. S., Demba E., Secka O., Easmon C. S. The dominance of a multiresistant strain of Neisseria gonorrhoeae among prostitutes and STD patients in The Gambia. Genitourin Med. 1992 Dec;68(6):356–360. doi: 10.1136/sti.68.6.356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jephcott A. E., Turner A. Ciprofloxacin resistance in gonococci. Lancet. 1990 Jan 20;335(8682):165–165. doi: 10.1016/0140-6736(90)90035-4. [DOI] [PubMed] [Google Scholar]
  12. Joesoef M. R., Knapp J. S., Idajadi A., Linnan M., Barakbah Y., Kamboji A., O'Hanley P., Moran J. S. Antimicrobial susceptibilities of Neisseria gonorrhoeae strains isolated in Surabaya, Indonesia. Antimicrob Agents Chemother. 1994 Nov;38(11):2530–2533. doi: 10.1128/aac.38.11.2530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kam K. M., Lai C. F., Egglestone S., Chan C. B. Patterns of antibiotic susceptibility of gonococci isolated in Hong Kong, 1987-1990. Sex Transm Dis. 1992 Sep-Oct;19(5):284–287. doi: 10.1097/00007435-199209000-00008. [DOI] [PubMed] [Google Scholar]
  14. Knapp J. S., Ohye R., Neal S. W., Parekh M. C., Higa H., Rice R. J. Emerging in vitro resistance to quinolones in penicillinase-producing Neisseria gonorrhoeae strains in Hawaii. Antimicrob Agents Chemother. 1994 Sep;38(9):2200–2203. doi: 10.1128/aac.38.9.2200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Knapp J. S., Washington J. A., Doyle L. J., Neal S. W., Parekh M. C., Rice R. J. Persistence of Neisseria gonorrhoeae strains with decreased susceptibilities to ciprofloxacin and ofloxacin in Cleveland, Ohio, from 1992 through 1993. Antimicrob Agents Chemother. 1994 Sep;38(9):2194–2196. doi: 10.1128/aac.38.9.2194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Loo P. S., Ridgway G. L., Oriel J. D. Single dose ciprofloxacin for treating gonococcal infections in men. Genitourin Med. 1985 Oct;61(5):302–305. doi: 10.1136/sti.61.5.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Nishimura M., Kumamoto Y., Hirose T., Sakai S., Tsukamoto T., Deguchi K. Bacteriologic studies on Neisseria gonorrhoeae isolated in Sapporo, Japan: investigation of beta-lactamase production and auxotypes. Sex Transm Dis. 1991 Apr-Jun;18(2):80–83. doi: 10.1097/00007435-199118020-00005. [DOI] [PubMed] [Google Scholar]
  18. Panikabutra K., Lee C. T., Ho B., Bamberg P. Single dose oral norfloxacin or intramuscular spectinomycin to treat gonorrhoea (PPNG and non-PPNG infections): analysis of efficacy and patient preference. Genitourin Med. 1988 Aug;64(4):235–240. doi: 10.1136/sti.64.4.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Tanaka M., Kumazawa J., Matsumoto T., Kobayashi I. High prevalence of Neisseria gonorrhoeae strains with reduced susceptibility to fluoroquinolones in Japan. Genitourin Med. 1994 Apr;70(2):90–93. doi: 10.1136/sti.70.2.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Tapsall J. W., Shultz T. R., Phillips E. A. Characteristics of Neisseria gonorrhoeae isolated in Australia showing decreased sensitivity to quinolone antibiotics. Pathology. 1992 Jan;24(1):27–31. doi: 10.3109/00313029209063616. [DOI] [PubMed] [Google Scholar]
  21. Van Dyck E., Rossau R., Duhamel M., Behets F., Laga M., Nzila M., Bygdeman S., Van Heuverswijn H., Piot P. Antimicrobial susceptibility of Neisseria gonorrhoeae in Zaire: high level plasmid-mediated tetracycline resistance in central Africa. Genitourin Med. 1992 Apr;68(2):111–116. doi: 10.1136/sti.68.2.111. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES